Skip to main content

Advertisement

SpringerLink
Log in

Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

WW domain-containing oxidoreductase (WWOX) gene located in the common fragile site FRA16D region exhibits loss or reduction of expression in multiple types of carcinomas including bladder cancer. However, the role of WWOX in the tumorigenesis and development of bladder cancer remains elusive. In this study, WWOX overexpression construct was transfected into 5637 bladder cancer cell line in which WWOX expression was compromised. Constitutive expression of ectopic WWOX in 5637 cells suppressed cell proliferation and cell cycle progression, which was associated with downregulation of Cyclin B, D1, and E. Moreover, WWOX overexpression promoted apoptosis in 5637 cells and resulted in upregulation of Bax, downregulation of Bcl-2, and elevated levels of cleaved caspase-3 and cleaved PARP, indicating activation of the intrinsic apoptosis pathway. Furthermore, WWOX overexpression suppressed tumorigenicity of 5637 cells and promoted apoptosis in the xenograft tumors as demonstrated in a xenograft mouse model. In summary, our data indicate that WWOX plays a critical role in the regulation of proliferation, cell cycle, apoptosis, and tumorigenesis of bladder cancer cells, suggesting that WWOX may have potential clinical implications in bladder cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nargund, V. H., Tanabalan, C. K., & Kabir, M. N. (2012). Management of non-muscle-invasive (superficial) bladder cancer. Seminars in Oncology, 39, 559–572.

    Article  CAS  PubMed  Google Scholar 

  2. Kiemeney, L. A., Witjes, J. A., Heijbroek, R. P., Verbeek, A. L., & Debruyne, F. M. (1993). Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. Journal of Urology, 150, 60–64.

    CAS  PubMed  Google Scholar 

  3. Sylvester, R. J., van der Meijden, A. P., Oosterlinck, W., Witjes, J. A., Bouffioux, C., et al. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. European Urology, 49, 466–477. (discussion 475–467).

    Article  PubMed  Google Scholar 

  4. Griffiths, T. R. (2013). Current perspectives in bladder cancer management. International Journal of Clinical Practice, 67, 435–448.

    Article  CAS  PubMed  Google Scholar 

  5. Carneiro, B. A., Meeks, J. J., Kuzel, T. M., Scaranti, M., Abdulkadir, S. A., et al. (2015). Emerging therapeutic targets in bladder cancer. Cancer Treatment Reviews, 41, 170–178.

    Article  CAS  PubMed  Google Scholar 

  6. Bednarek, A. K., Laflin, K. J., Daniel, R. L., Liao, Q., Hawkins, K. A., et al. (2000). WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Research, 60, 2140–2145.

    CAS  PubMed  Google Scholar 

  7. Kuroki, T., Trapasso, F., Shiraishi, T., Alder, H., Mimori, K., et al. (2002). Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Research, 62, 2258–2260.

    CAS  PubMed  Google Scholar 

  8. Yendamuri, S., Kuroki, T., Trapasso, F., Henry, A. C., Dumon, K. R., et al. (2003). WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Research, 63, 878–881.

    CAS  PubMed  Google Scholar 

  9. Kuroki, T., Yendamuri, S., Trapasso, F., Matsuyama, A., Aqeilan, R. I., et al. (2004). The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clinical Cancer Research, 10, 2459–2465.

    Article  CAS  PubMed  Google Scholar 

  10. Aqeilan, R. I., Kuroki, T., Pekarsky, Y., Albagha, O., Trapasso, F., et al. (2004). Loss of WWOX expression in gastric carcinoma. Clinical Cancer Research, 10, 3053–3058.

    Article  CAS  PubMed  Google Scholar 

  11. Jenner, M. W., Leone, P. E., Walker, B. A., Ross, F. M., Johnson, D. C., et al. (2007). Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. Blood, 110, 3291–3300.

    Article  CAS  PubMed  Google Scholar 

  12. Park, S. W., Ludes-Meyers, J., Zimonjic, D. B., Durkin, M. E., Popescu, N. C., et al. (2004). Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. British Journal of Cancer, 91, 753–759.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Qin, H. R., Iliopoulos, D., Semba, S., Fabbri, M., Druck, T., et al. (2006). A role for the WWOX gene in prostate cancer. Cancer Research, 66, 6477–6481.

    Article  CAS  PubMed  Google Scholar 

  14. Lan, C., Chenggang, W., Yulan, B., Xiaohui, D., Junhui, Z., et al. (2012). Aberrant expression of WWOX protein in epithelial ovarian cancer: A clinicopathologic and immunohistochemical study. International Journal of Gynecological Pathology, 31, 125–132.

    Article  PubMed  Google Scholar 

  15. Ramos, D., Abba, M., Lopez-Guerrero, J. A., Rubio, J., Solsona, E., et al. (2008). Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours. Histopathology, 52, 831–839.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Pluciennik, E., Kusinska, R., Potemski, P., Kubiak, R., Kordek, R., et al. (2006). WWOX–the FRA16D cancer gene: Expression correlation with breast cancer progression and prognosis. European Journal of Surgical Oncology, 32, 153–157.

    Article  CAS  PubMed  Google Scholar 

  17. Guler, G., Uner, A., Guler, N., Han, S. Y., Iliopoulos, D., et al. (2004). The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer, 100, 1605–1614.

    Article  CAS  PubMed  Google Scholar 

  18. Nunez, M. I., Rosen, D. G., Ludes-Meyers, J. H., Abba, M. C., Kil, H., et al. (2005). WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer, 5, 64.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Knudson, A. G, Jr. (1985). Hereditary cancer, oncogenes, and antioncogenes. Cancer Research, 45, 1437–1443.

    CAS  PubMed  Google Scholar 

  20. Aqeilan, R. I., Trapasso, F., Hussain, S., Costinean, S., Marshall, D., et al. (2007). Targeted deletion of Wwox reveals a tumor suppressor function. Proceedings of the National Academy of Sciences USA, 104, 3949–3954.

    Article  CAS  Google Scholar 

  21. Iliopoulos, D., Guler, G., Han, S. Y., Johnston, D., Druck, T., et al. (2005). Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene, 24, 1625–1633.

    Article  CAS  PubMed  Google Scholar 

  22. Pluciennik, E., Nowakowska, M., Stepien, A., Wolkowicz, M., Stawinski, A., et al. (2014). Alternating expression levels of tumor suppressor and cancer-related genes in patients with bladder cancer. Oncology Letters, 8, 2291–2297.

    PubMed  PubMed Central  Google Scholar 

  23. Bednarek, A. K., Keck-Waggoner, C. L., Daniel, R. L., Laflin, K. J., Bergsagel, P. L., et al. (2001). WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Research, 61, 8068–8073.

    CAS  PubMed  Google Scholar 

  24. Fabbri, M., Iliopoulos, D., Trapasso, F., Aqeilan, R. I., Cimmino, A., et al. (2005). WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proceedings of the National Academy of Sciences USA, 102, 15611–15616.

    Article  CAS  Google Scholar 

  25. Gourley, C., Paige, A. J., Taylor, K. J., Ward, C., Kuske, B., et al. (2009). WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Research, 69, 4835–4842.

    Article  CAS  PubMed  Google Scholar 

  26. Kurek, K. C., Del Mare, S., Salah, Z., Abdeen, S., Sadiq, H., et al. (2010). Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Research, 70, 5577–5586.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Tomayko, M. M., & Reynolds, C. P. (1989). Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemotherapy and Pharmacology, 24, 148–154.

    Article  CAS  PubMed  Google Scholar 

  28. Nowakowska, M., Pluciennik, E., Wujcicka, W. I., Sitkiewicz, A., Kazanowska, B., et al. (2014). The correlation analysis of WWOX expression and cancer related genes in neuroblastoma-a real time RT-PCR study. Acta Biochimica Polonica, 61, 91–97.

    PubMed  Google Scholar 

  29. Zelazowski, M. J., Pluciennik, E., Pasz-Walczak, G., Potemski, P., Kordek, R., et al. (2011). WWOX expression in colorectal cancer—a real-time quantitative RT-PCR study. Tumour Biology, 32, 551–560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Pluciennik, E., Nowakowska, M., Wujcicka, W. I., Sitkiewicz, A., Kazanowska, B., et al. (2012). Genetic alterations of WWOX in Wilms’ tumor are involved in its carcinogenesis. Oncology Reports, 28, 1417–1422.

    CAS  PubMed  Google Scholar 

  31. Xiong, Z., Hu, S., & Wang, Z. (2010). Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells. Journal of Huazhong University of Science and Technology Medical Sciences, 30, 365–369.

    Article  CAS  Google Scholar 

  32. Yang, Z., Lan, H., Chen, X., Li, P., Li, S., et al. (2014). Molecular alterations of the WWOX gene in nasopharyngeal carcinoma. Neoplasma, 61, 170–176.

    Article  CAS  PubMed  Google Scholar 

  33. Iliopoulos, D., Fabbri, M., Druck, T., Qin, H. R., Han, S. Y., et al. (2007). Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of Wwox expression. Clinical Cancer Research, 13, 268–274.

    Article  CAS  PubMed  Google Scholar 

  34. Paige, A. J., Taylor, K. J., Taylor, C., Hillier, S. G., Farrington, S., et al. (2001). WWOX: A candidate tumor suppressor gene involved in multiple tumor types. Proceedings of the National Academy of Sciences USA, 98, 11417–11422.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Urology, Liaoning Cancer Hospital and Institute, 44 Xiaoheyan Road, Shenyang, 110042, People’s Republic of China

      Gang Li, Zhongyi Mu, Yan Huang, Cheng Fu & Bin Hu

    2. Department of Respiratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, People’s Republic of China

      Longfeng Sun

    Authors
    1. Gang Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Longfeng Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Zhongyi Mu
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yan Huang
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Cheng Fu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Bin Hu
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Bin Hu.

    Additional information

    Gang Li and Longfeng Sun have contributed equally to this study.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Li, G., Sun, L., Mu, Z. et al. Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo. Cell Biochem Biophys 73, 417–425 (2015). https://doi.org/10.1007/s12013-015-0654-0

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12013-015-0654-0

    Keywords

    Search

    Navigation